Head-to-head · Value Score
Alan Meds vs HealthRX
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, HealthRX a 86. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#5 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameHealthRX
#19 · Grade A- · Great Deal
Est. first month
$189/mo
Save ~86% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 86 — an est. $99/mo first month, with no teaser step-up baked in. HealthRX isn't out of it: Needle-averse shoppers who want a verified, physician-supervised program with a real oral GLP-1 tablet option and don't need a published state list.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | HealthRX |
|---|---|---|
| Value Score | 90 (A) | 86 (A-) |
| Est. first month | $99/mo | $189/mo |
| Save vs brand-name | ~93% | ~86% |
| Semaglutide | $99/mo | $189/mo |
| Tirzepatide | $145/mo | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not publicly listed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
HealthRX
A LegitScript-certified, physician-supervised program that's one of the few offering a genuine oral GLP-1 tablet alongside injectable — with transparent flat monthly pricing and no insurance required.
Why it's a deal
- LegitScript-certified (#50087439) — a genuine third-party trust signal
- Physician-supervised telehealth with licensed-provider intake
- Both molecules plus a rare oral GLP-1 tablet for the needle-averse
- Transparent flat monthly pricing with no insurance required
The fine print
- Compounded medication is not FDA-approved
- Some pricing tiers are company-stated and the site is thin — confirm before you buy
- Brand-name tiers are an expensive pass-through (Ozempic ~$1,299/mo)
- States served are not publicly listed — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.